1. Home
  2. RRBI vs LCTX Comparison

RRBI vs LCTX Comparison

Compare RRBI & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Red River Bancshares Inc.

RRBI

Red River Bancshares Inc.

HOLD

Current Price

$75.75

Market Cap

484.1M

ML Signal

HOLD

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

HOLD

Current Price

$1.71

Market Cap

407.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RRBI
LCTX
Founded
1998
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
484.1M
407.7M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
RRBI
LCTX
Price
$75.75
$1.71
Analyst Decision
Buy
Strong Buy
Analyst Count
1
4
Target Price
$67.00
$4.25
AVG Volume (30 Days)
35.7K
1.2M
Earning Date
01-30-2026
03-09-2026
Dividend Yield
0.80%
N/A
EPS Growth
26.56
N/A
EPS
6.01
N/A
Revenue
$119,363,000.00
$10,816,000.00
Revenue This Year
N/A
$6.32
Revenue Next Year
$6.57
$124.49
P/E Ratio
$12.48
N/A
Revenue Growth
12.57
24.05
52 Week Low
$46.33
$0.37
52 Week High
$78.01
$2.09

Technical Indicators

Market Signals
Indicator
RRBI
LCTX
Relative Strength Index (RSI) 63.02 50.38
Support Level $71.23 $1.64
Resistance Level $73.81 $1.79
Average True Range (ATR) 2.02 0.09
MACD 0.17 0.00
Stochastic Oscillator 96.90 51.92

Price Performance

Historical Comparison
RRBI
LCTX

About RRBI Red River Bancshares Inc.

Red River Bancshares Inc is the bank holding company for the red river bank. The principal business of the Bank is lending and accepting deposits from businesses, professionals, individuals, and public entities. The bank's primary deposit products are demand deposits, savings deposits, and time deposits. The bank maintains a diversified loan portfolio with a focus on commercial real estate (Owner Occupied and Non-Owner Occupied), one-to-four-family residential, commercial, and industrial loans, construction and development Loans, and others. also, provides Treasury Management Services, Private Banking Services, Brokerage Services, and Other Banking Services.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

Share on Social Networks: